The anti-tumor effect of bisphosphonates ABCSG-12, ZO-FAST and more ...
Gnant
Michael
M
Medical University of Vienna; Austrian Breast & Colorectal Cancer Group, Austria. michael.gnant@meduniwien.ac.at
Eidtmann
Holger
H
D000970:Antineoplastic Agents / Q000008:administration & dosage / Q000627:therapeutic use*; D050071:Bone Density Conservation Agents / Q000008:administration & dosage / Q000627:therapeutic use*; D001943:Breast Neoplasms / Q000188:drug therapy*; D017024:Chemotherapy, Adjuvant; D004164:Diphosphonates / Q000008:administration & dosage / Q000627:therapeutic use*; D064420:Drug-Related Side Effects and Adverse Reactions; D005260:Female; D006801:Humans; D007093:Imidazoles / Q000627:therapeutic use; D000077211:Zoledronic Acid
D000970:Antineoplastic Agents; D050071:Bone Density Conservation Agents; D004164:Diphosphonates; D007093:Imidazoles; D000077211:Zoledronic Acid